|
Optimized Cutoffs Improve Performance of the Aspartate Aminotransferase to Platelet Ratio Index for Predicting Significant Liver Fibrosis in Human Immunodeficiency Virus/Hepatitis C Virus Co-infection
Mardi 08 Juillet 2008 - 11:30 - 6 mois depuis - Presse spécialisée - Medscape HIV AIDS Can modified cutoffs for aspartate aminotransferase to platelet ratio index predict liver fibrosis in HIV/hepatitis C co-infection? Could some biopsies be prevented by using this method? Liver International |
|
Effects of Depression and Selective Serotonin Reuptake Inhibitor use on Adherence to Highly Active Antiretroviral Therapy and on Clinical Outcomes in HIV-infected Patients
Mardi 08 Juillet 2008 - 09:50 - 6 mois depuis - Presse spécialisée - Medscape HIV AIDS Does depression significantly worsens HAART adherence and HIV viral control? JAIDS: Journal of Acquired Immune Deficiency Syndromes |
|
IL-7 Therapy Boosts Immune Response in Cancer Patients
Vendredi 04 Juillet 2008 - 12:47 - 6 mois, 1 semaine depuis - Presse spécialisée - Medscape HIV AIDS Treatment with recombinant human interleukin-7 was shown to safely induce polyclonal T cell expansion, resulting in dramatic increases in T cell numbers, in patients with refractory cancer Medscape Medical News |
|
Examining Racial Disparities in HIV: Lessons From Sexually Transmitted Infections Research
Jeudi 03 Juillet 2008 - 11:40 - 6 mois, 1 semaine depuis - Presse spécialisée - Medscape HIV AIDS In this article 15 factors are identified in the sexually transmitted infection (STI) literature to explain the presence of racial/ethnic disparities in STIs. JAIDS: Journal of Acquired Immune Deficiency Syndromes |
|
Bush Urges Congress to Pass AIDS Funds
Mercredi 02 Juillet 2008 - 19:51 - 6 mois, 1 semaine depuis - Presse spécialisée - Medscape HIV AIDS President George W. Bush urged Congress on Wednesday to approve funds to fight AIDS in Africa and other countries, and said the issue was high on his agenda for a Group of Eight summit in Japan next week. Reuters Health Information |
|
Long-term Survival and Serious Cardiovascular Events in HIV-infected Patients Treated With Highly Active Antiretroviral Therapy
Mercredi 02 Juillet 2008 - 14:06 - 6 mois, 1 semaine depuis - Presse spécialisée - Medscape HIV AIDS There is continuing interest in the longer term effects of highly active antiretroviral therapy (HAART) on the risk of cardiopulmonary events. JAIDS: Journal of Acquired Immune Deficiency Syndromes |
|
FDA Safety Changes: Atripla, Halcion, Restoril
Mercredi 02 Juillet 2008 - 12:00 - 6 mois, 1 semaine depuis - Presse spécialisée - Medscape HIV AIDS The FDA has approved revisions to the safety labeling for efavirenz plus emtricitabine and tenofovir disoproxil fumarate tablets, triazolam tablets, and temazepam capsules. Medscape Medical News |
|
Practice Makes Perfect: A Volume-outcome Study of Hospital Patients With HIV Disease
Mercredi 02 Juillet 2008 - 07:52 - 6 mois, 1 semaine depuis - Presse spécialisée - Medscape HIV AIDS The number of HIV-positive patients treated in a hospital and the number of HIV-positive patients treated by the attending physician are examined. What is the probability of dying in the hospital? JAIDS: Journal of Acquired Immune Deficiency Syndromes |
|
HIV-Related Mortality Near Normal in First 5 Years on HAART
Mardi 01 Juillet 2008 - 18:46 - 6 mois, 1 semaine depuis - Presse spécialisée - Medscape HIV AIDS In countries with good patient access to highly active antiretroviral therapy (HAART), persons infected with HIV currently experience mortality rates similar to that of the general population in the first 5 years after seroconversion, members of the CASCADE (Concerted Action on Seroconversion to AIDS and Death in Europe) collaboration report. Reuters Health Information |
|
Determinants of HIV Progression and Assessment of the Optimal Time to Initiate Highly Active Antiretroviral Therapy: PISCIS Cohort (Spain)
Mardi 01 Juillet 2008 - 15:09 - 6 mois, 1 semaine depuis - Presse spécialisée - Medscape HIV AIDS When is the best time to start HAART; before the CD4 count falls to lower than 350 cells/microL? JAIDS: Journal of Acquired Immune Deficiency Syndromes |
< 1 – 2 – 3 – 4 – 5 – 6 – 7 – 8 – 9 – 10 – 11 – 12 – 13 – 14 – 15 – 16 – 17 – 18 – 19 – 20 >
Actus fournies par : Medscape HIV/AIDS Headlines